JOINT PRODUCT CONTAINING SYNEPHRINE AND TOPIRAMATE

摘要

Provided in the present invention is a joint product containing synephrine and topiramate, where the synephrine or a salt thereof is administered in the form of an immediate-release preparation, preferably an immediate-release pellet, with a daily dosage between 2 mg and 25 mg, preferably between 5 mg and 20 mg, and where the topiramate is administered in the form of a sustained-release or controlled-release preparation, preferably a sustained-release pellet, with a daily dosage between 20 mg and 100 mg, preferably between 23 mg and 92 mg. The composition is for use in treatment of obesity and other diseases related to obesity.